How to Check Prasol Chemicals IPO Allotment Status

Prasol Chemicals Limited is a speciality chemicals manufacturer with more than three decades of operating experience. Incorporated in 1992, the company is a forward-integrated manufacturer of acetone-based, phosphorus-based and other speciality chemicals involving complex and differentiated chemistries. 

The company has a diversified portfolio of more than 150 speciality chemical products, including 21 acetone-based chemicals, 53 phosphorus-based chemicals and 76 other speciality chemicals. These products cater to industries including performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care. 

Prasol Chemicals operates two manufacturing facilities at Khopoli and Mahad in Maharashtra, with an aggregate installed capacity of 98,644 tonnes per annum in FY26. The Khopoli facility recorded capacity utilisation of 80.29%, while utilisation at the Mahad facility stood at 44.09% during FY26. 

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

As of July 15, 2026, the company had more than 1,600 customers and an export presence across 69 countries. Exports contributed 27.29% of FY26 revenue from operations. 

Prasol Chemicals IPO is a ₹500 crore book-built mainboard issue, comprising a fresh issue of ₹80 crore and an offer for sale of ₹420 crore. The fresh issue comprises approximately 11.83 lakh shares, while the OFS comprises approximately 62.13 lakh shares. 

The IPO opened for subscription on September 8, 2026 and closed on September 10, 2026. The basis of allotment is scheduled for September 11, 2026, followed by refunds and credit of shares on September 15. The shares are scheduled to list on BSE and NSE on September 16, 2026. 

The price band was fixed at ₹643 to ₹676 per share, with a lot size of 22 shares. At the upper price band, the minimum Retail Investor application for one lot amounts to ₹14,872. 

DAM Capital Advisors Limited is the book-running lead manager to the issue, while KFin Technologies Limited is the registrar. 

Registrar: KFin Technologies Limited

BSE: BSE IPO Allotment Status Page

NSE: NSE IPO Allotment Status Page

Prasol Chemicals IPO Subscription Status 

Prasol Chemicals IPO was subscribed 3.44 times as of 4:14 PM on Day 3, September 10, 2026, based on the supplied subscription snapshot. At that point, QIBs recorded the highest subscription among the investor categories.

The QIB category recorded the highest demand in the supplied final-day snapshot, reaching 7.59 times. Institutional participation was negligible during the first two days, at zero on Day 1 and 0.06 times on Day 2, before increasing during the closing session. 

The NII category was subscribed 1.86 times in the supplied Day 3 snapshot. NII subscription increased from 0.33 times on the opening day to 0.69 times on Day 2 before crossing full subscription on the final day. 

The Retail category was subscribed 1.75 times in the supplied snapshot. Retail subscription increased from 0.73 times on Day 1 to 1.19 times on Day 2, before rising further during the final session. 

Overall subscription increased from 0.44 times on Day 1 to 0.76 times on Day 2, before reaching 3.44 times at the supplied Day 3 cut-off. 

Later final exchange-linked data recorded the IPO at 3.47 times overall, with QIBs subscribed 7.59 times, NIIs 1.89 times and Retail Investors 1.79 times. At that stage, the public issue had received bids for approximately 1.80 crore shares against 51.78 lakh shares available for subscription, excluding the anchor portion. The table above retains the supplied 3.44-times snapshot for consistency. 

Prasol Chemicals IPO Share Price and Investment Details 

Prasol Chemicals IPO price band was fixed at ₹643 to ₹676 per share, with a lot size of 22 shares. At the upper price of ₹676, the minimum Retail Investor application for one lot requires an investment of ₹14,872. 

Retail Investors can apply for up to 13 lots or 286 shares, corresponding to an investment of ₹1,93,336 at the upper price band. The minimum sNII application starts from 14 lots or 308 shares, requiring an investment of ₹2,08,208. 

The total IPO size is ₹500 crore, comprising an ₹80 crore fresh issue and a ₹420 crore OFS. At the upper end of the price band, the offer comprises approximately 73.96 lakh shares. 

The IPO reservation comprises approximately 36.98 lakh shares for QIBs including anchor investors, 11.09 lakh shares for NIIs and 25.89 lakh shares for Retail Investors. Of the QIB allocation, approximately 22.19 lakh shares were allotted to anchor investors. 

Based on the supplied closing snapshot, QIBs led demand at 7.59 times, followed by NIIs at 1.86 times and Retail Investors at 1.75 times. Overall subscription stood at 3.44 times at the supplied cut-off. 

The basis of allotment is scheduled for September 11, 2026, followed by refunds and share credit on September 15 and the proposed BSE and NSE listing on September 16. 

Utilisation of IPO Proceeds 

Prasol Chemicals proposes to utilise ₹60 crore from the fresh issue proceeds towards repayment or prepayment, in full or in part, of certain outstanding borrowings availed by the company. 

This allocation represents approximately 75% of the ₹80 crore gross fresh issue, with the proposed debt repayment intended to reduce outstanding borrowings and associated financing obligations. 

The remaining eligible net proceeds from the fresh issue are proposed to be utilised towards general corporate purposes, subject to applicable regulatory limits and deduction of issue-related expenses. 

The IPO also includes an OFS of ₹420 crore, representing 84% of the total ₹500 crore issue. The OFS comprises approximately 62.13 lakh shares. Proceeds from this portion will accrue to the selling shareholders and will not be available to Prasol Chemicals for debt repayment or other corporate requirements. 

Business Overview 

Prasol Chemicals operates in the speciality chemicals industry, manufacturing acetone-based, phosphorus-based and other chemicals involving differentiated chemistries. Its products are used as raw materials, intermediates and performance-enhancing chemicals across several industrial applications. 

Its portfolio includes more than 150 speciality chemical products, with another 40 products under various stages of development as of June 30, 2026. The company's portfolio includes 21 acetone-based speciality chemicals, 53 phosphorus-based speciality chemicals and 76 other products, including surfactants, performance additives, ethers, esters, polymers and acids. 

The company's products serve five principal application segments: performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care. In FY26, acetone-based chemicals contributed 42.75% of revenue from operations, phosphorus-based chemicals contributed 38.30%, while other speciality chemicals contributed 18.33%. 

Prasol Chemicals operates manufacturing facilities at Khopoli and Mahad in Maharashtra, supported by an in-house research and development centre. Aggregate installed manufacturing capacity stood at 98,644 tonnes per annum in FY26. Capacity utilisation was 80.29% at Khopoli and 44.09% at Mahad. 

The company served 1,618 customers in FY26, while its international network extended across 69 countries as of July 15, 2026. Exports contributed approximately 27.29% of FY26 revenue from operations, while its top 10 customers accounted for 23.68%. 

Prasol Chemicals reported total income of ₹1,237.85 crore in FY26, compared with ₹1,015.54 crore in FY25 and ₹887.56 crore in FY24. Profit after tax increased to ₹83.12 crore in FY26, from ₹43.57 crore in FY25 and ₹18.13 crore in FY24. 

EBITDA increased to approximately ₹139.32 crore in FY26, compared with ₹87.77 crore in FY25 and ₹60.53 crore in FY24. Net worth stood at ₹448.51 crore as of March 31, 2026, while total borrowings were approximately ₹110.06 crore. 

Key strengths include the company's diversified speciality chemical portfolio, long operating history, established domestic and export customer base, multiple chemistry platforms, in-house R&D capabilities and manufacturing presence across two facilities. 

Investors should also consider risks associated with raw-material price volatility, dependence on key suppliers, product concentration, environmental and regulatory compliance, export and foreign-exchange exposure, and manufacturing utilisation. The top 10 suppliers accounted for nearly 69% of input purchases, while acetone-based speciality chemicals contributed more than 42% of FY26 revenue. Capacity utilisation at the Mahad facility also remained at 44.09% in FY26.